디히드로찬도늄

Dihydrochandonium
디히드로찬도늄
Dihydrochandonium.svg
이름
IUPAC 이름
(4aS,4bR,6aS,8R,10aS,10bS,12aS)-1,1,10a,12a-tetramethyl-8-(1-methylpyrrolidin-1-ium-1-yl)-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydro-2H-naphtho[2,1-f]quinolin-1-ium
기타 이름
두아도르
식별자
  • 디브로마이드: 70433-02-2 ☒N
3D 모델(JSmol)
켐스파이더
펍켐 CID
  • InChi=1S/C26H48N2.2HI/c1-25-14-12-21(28(5)17-6-7-18-28)19-20(25)10-11-22-23(25)13-15-26(2)24(22)9-8-16-27(26,3)4;;/h20-24H,6-19H2,1-5H3;2*1H/q+2;;/p-2/t20-,21-,22+,23-,24-,25-,26-;;/m0../s1
    키: ZLFADLFGBBXRJ-SPPKVZINSA-L
  • 디브로마이드: InChI=1S/C26H48N2.2BrH/c1-25-14-12-21(28(5)17-6-7-18-28)19-20(25)10-11-22-23(25)13-15-26(2)24(22)9-8-16-27(26,3)4;;/h20-24H,6-19H2,1-5H3;2*1H/q+2;;/p-2/t20-,21+,22+,23-,24-,25-,26-;;/m0../s1
    키: PDNBZMXDIQRBZ-KMYXDLQKSA-L
  • 다이오다이오드: InChi=1S/C26H48N2.2HI/c1-25-14-12-21(28(5)17-6-7-18-28)19-20(25)10-11-22-23(25)13-15-26(2)24(22)9-8-16-27(26,3)4;;/h20-24H,6-19H2,1-5H3;2*1H/q+2;;/p-2/t20-,21-,22+,23-,24-,25-,26-;;/m0../s1
    키: ZLFADLFGBBXRJ-SPPKVZINSA-L
  • C[C@]12CC[C@H](C[C@H])1CC[C@H]3[C@H]2CC[C@]4([C@H]3)CCC[N+]4(C)C)[N+]5(CCCCC5)C
  • 디브로마이드: C[C@]12CC[C@H](C[C@@H])1CC[C@H]3[C@H]2CC[C@]4([C@H]3)CCC[N+]4(C)C)[N+]5(CCCCC5)C.[Br-][Br-]
  • 다이오다이오드: C[C@]12CC[C@H](C[C@H])1CC[C@H]3[C@H]2CC[C@]4([C@H]3)CCC[N+]4(C)C)[N+]5(CCCCC5)C.[I-][I-]
특성.
C26H48N2−2
어금질량 388.685 g·1998−1
달리 명시된 경우를 제외하고, 표준 상태(25°C [77°F], 100 kPa)의 재료에 대한 데이터가 제공된다.
Infobox 참조 자료

디히드로찬도늄아미노스테로이드 비분극 신경근 차단제다.[1]

참조

  1. ^ Fitzal, S; Ilias, W; Kalina, K; Schwarz, S; Foldes, FF; Steinbereithner, K (1982). "Neuromuscular and cardiovascular effects of Duador, a new short-acting nondepolarizing muscle relaxant". Der Anaesthesist. 31 (12): 674–9. PMID 6299129.